Clinical Trial Update: A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating relative bioavailability, food effect, and gastric pH modification on TAK-117 pharmacokinetics in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm Advanced or Metastatic

Drugs mentioned

• TAK-117

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Neoplasm, Advanced or Metastatic | Phase 1 | Status: COMPLETED | Results posted: 2018-01-08